The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date.
Sophie M BruinsmaLiying ZhangMonique J RoobolChris H BangmaEwout W SteyerbergDaan NieboerMieke Van Hemelrijcknull nullPublished in: BJU international (2018)
GAP3 is the largest worldwide collaboration integrating patient data from men with PCa on AS. The results will allow individual patients and clinicians to have greater confidence in the personalized decision to either delay or proceed with active treatment. Longer follow-up and the evaluation of MRI, new genomic markers and patient-related outcomes will result in even more valuable data and eventually in better patient outcomes.
Keyphrases
- prostate cancer
- end stage renal disease
- electronic health record
- case report
- chronic kidney disease
- newly diagnosed
- big data
- ejection fraction
- magnetic resonance imaging
- peritoneal dialysis
- radical prostatectomy
- palliative care
- gene expression
- type diabetes
- machine learning
- patient reported outcomes
- computed tomography
- copy number
- data analysis
- middle aged
- insulin resistance
- weight loss